189 related articles for article (PubMed ID: 31464629)
1. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
de Salazar Alcalá AG; Gioda L; Dehman A; Beugnet F
BMC Vet Res; 2019 Aug; 15(1):309. PubMed ID: 31464629
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.
Vijarnsorn M; Kwananocha I; Kashemsant N; Jarudecha T; Lekcharoensuk C; Beale B; Peirone B; Lascelles BDX
BMC Vet Res; 2019 Oct; 15(1):349. PubMed ID: 31623621
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs.
Hazewinkel HA; van den Brom WE; Theyse LF; Pollmeier M; Hanson PD
Res Vet Sci; 2008 Feb; 84(1):74-9. PubMed ID: 17408711
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two inhibitors of E-type prostanoid receptor four and carprofen in dogs with experimentally induced acute synovitis.
Budsberg SC; Kleine SA; Norton MM; Sandberg GS
Am J Vet Res; 2019 Nov; 80(11):1001-1006. PubMed ID: 31644340
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
[TBL] [Abstract][Full Text] [Related]
6. The effects of firocoxib (Previcox) in geriatric dogs over a period of 90 days.
Joubert KE
J S Afr Vet Assoc; 2009 Sep; 80(3):179-84. PubMed ID: 20169752
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
[TBL] [Abstract][Full Text] [Related]
8. Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.
Drag M; Kunkle BN; Romano D; Hanson PD
Vet Ther; 2007; 8(1):41-50. PubMed ID: 17447224
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis.
Cathcart CJ; Johnston SA; Reynolds LR; Al-Nadaf S; Budsberg SC
Am J Vet Res; 2012 Jan; 73(1):19-26. PubMed ID: 22204284
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
Orsini JA; Ryan WG; Carithers DS; Boston RC
Am J Vet Res; 2012 May; 73(5):664-71. PubMed ID: 22533398
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
Autefage A; Palissier FM; Asimus E; Pepin-Richard C
Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
Ryan WG; Moldave K; Carithers D
Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
[TBL] [Abstract][Full Text] [Related]
13. A Prospective, Randomized, Masked, Placebo-Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis.
Rausch-Derra L; Huebner M; Wofford J; Rhodes L
J Vet Intern Med; 2016 May; 30(3):756-63. PubMed ID: 27075237
[TBL] [Abstract][Full Text] [Related]
14. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
Doucet MY; Bertone AL; Hendrickson D; Hughes F; Macallister C; McClure S; Reinemeyer C; Rossier Y; Sifferman R; Vrins AA; White G; Kunkle B; Alva R; Romano D; Hanson PD
J Am Vet Med Assoc; 2008 Jan; 232(1):91-7. PubMed ID: 18167116
[TBL] [Abstract][Full Text] [Related]
15. The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
Back W; MacAllister CG; van Heel MC; Pollmeier M; Hanson PD
Equine Vet J; 2009 Mar; 41(3):309-12. PubMed ID: 19469242
[TBL] [Abstract][Full Text] [Related]
16. Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
de Salazar Alcalá AG; Gioda L; Dehman A; Beugnet F
BMC Vet Res; 2019 Oct; 15(1):347. PubMed ID: 31619253
[TBL] [Abstract][Full Text] [Related]
17. Tolerance of firocoxib in dogs with osteoarthritis during 90 days.
Lecoindre O; Pepin-Richard C
J Vet Pharmacol Ther; 2011 Apr; 34(2):190-2. PubMed ID: 21395612
[No Abstract] [Full Text] [Related]
18. Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model.
Goodman L; Torres B; Punke J; Reynolds L; Speas A; Ellis A; Budsberg S
J Vet Intern Med; 2009; 23(1):56-62. PubMed ID: 19175721
[TBL] [Abstract][Full Text] [Related]
19. Switching NSAIDs in practice: insights from the Previcox (firocoxib) Experience Trial.
Ryan WG; Moldave K; Carithers D
Vet Ther; 2007; 8(4):263-71. PubMed ID: 18183545
[TBL] [Abstract][Full Text] [Related]
20. Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.
Ziegler AL; Freeman CK; Fogle CA; Burke MJ; Davis JL; Cook VL; Southwood LL; Blikslager AT
Equine Vet J; 2019 May; 51(3):329-335. PubMed ID: 30156312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
